A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced
- This topic has 0 replies, 1 voice, and was last updated 6 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.
https://www.ncbi.nlm.nih.gov/pubmed/28972963
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.